We are live on ! Find out more
PRAH

PRA Health Sciences, Inc.
PRAH

Delisted

PRAH was delisted on the 30th of June, 2021.

342 hedge funds and large institutions have $7.01B invested in PRA Health Sciences, Inc. in 2018 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 140 increasing their positions, 105 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 21

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

33% more repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 105

16% more capital invested

Capital invested by funds: $6.04B → $7.01B (+$974M)

14% more funds holding

Funds holding: 300342 (+42)

53% less call options, than puts

Call options by funds: $6.04M | Put options by funds: $12.9M

Holders
342
Holders Change
+42
Holders Change %
+14%
% of All Funds
7.82%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.16%
New
65
Increased
140
Reduced
105
Closed
21
Calls
$6.04M
Puts
$12.9M
Net Calls
-$6.85M
Net Calls Change
-$1.48M
Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$738M -$677M -6,500,000 -49%
BlackRock
2
BlackRock
New York
$669M +$67.4M +647,401 +12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$640M +$68.5M +658,191 +13%
Capital Research Global Investors
4
Capital Research Global Investors
California
$436M +$10.1K +97 +0%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$287M +$115M +1,104,370 +74%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$272M +$27.9M +268,243 +12%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$255M +$2.27M +21,818 +1%
DZ Bank
8
DZ Bank
Germany
$180M +$20.9M +200,528 +14%
State Street
9
State Street
Massachusetts
$160M +$18.5M +177,322 +14%
Ameriprise
10
Ameriprise
Minnesota
$136M -$37.6M -361,528 -23%
EAM
11
Eagle Asset Management
Florida
$118M +$4.15M +39,839 +4%
BAMCO Inc
12
BAMCO Inc
New York
$105M
Swedbank
13
Swedbank
Sweden
$105M +$99M +951,100 New
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$103M -$8.26M -79,362 -8%
Wells Fargo
15
Wells Fargo
California
$97.9M -$9.17M -88,083 -9%
Goldman Sachs
16
Goldman Sachs
New York
$93.8M -$1.48M -14,260 -2%
Jennison Associates
17
Jennison Associates
New York
$91.9M +$21.7M +208,156 +33%
CTA
18
Carillon Tower Advisers
Florida
$88.4M +$4.26M +40,946 +5%
FCM
19
Frontier Capital Management
Massachusetts
$78.1M +$73.8M +709,009 New
VOYA Investment Management
20
VOYA Investment Management
Georgia
$77.7M -$33.2M -319,098 -31%
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$76.5M +$7.93M +76,136 +12%
AQR Capital Management
22
AQR Capital Management
Connecticut
$76.4M +$58.5M +562,233 +430%
CS
23
Credit Suisse
Switzerland
$66.8M +$10.6M +102,041 +20%
Norges Bank
24
Norges Bank
Norway
$63.8M +$3.93M +37,779 +7%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$60.5M +$6.63M +63,662 +13%

PRAH Hedge Fund Activity: Q3 2018 in Review

342 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q3 2018, worth a combined $7.01B — up 16% from $6.04B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new PRAH positions and 21 closed out — a net gain of 44 holders — while 140 added to existing stakes and 105 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $115M. The largest seller was Kohlberg Kravis Roberts & Co, cutting an estimated $677M.

  • 342 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q3 2018, up from 300 in Q2 2018.
  • Funds reported $7.01B of PRA Health Sciences, Inc. stock for Q3 2018, up 16% quarter-over-quarter.
  • 65 funds opened new PRA Health Sciences, Inc. positions in Q3 2018 and 21 closed out, a net change of +44 holders.
  • The largest PRA Health Sciences, Inc. buyer in Q3 2018 was Wellington Management Group, an estimated $115M added.
  • The largest PRA Health Sciences, Inc. seller in Q3 2018 was Kohlberg Kravis Roberts & Co, an estimated $677M sold.

Based on aggregated 13F filings for Q3 2018.